Healthplus.ai vs Luminare (2026)
Two vendors who both think this category measures the wrong thing, for different reasons. Healthplus.ai says the problem is calibration rather than discrimination, and its published evaluation is the most methodologically complete in this category, treating the fact that a model moving between hospitals misestimates absolute risk as the central issue rather than a footnote. Luminare says prediction was never the constraint at all: hospitals already know who is at risk and fail at the bundle and the workflow that follow, and it publishes the best commercial disclosure and implementation ladder in the lane. Both critiques are correct and they compound. A miscalibrated score firing into a ward that cannot act on it is the actual state of sepsis screening in most hospitals, and neither vendor alone fixes both halves.
- The published evaluation is the most methodologically complete in this category, appearing in a regional journal of a major medical publisher rather than in vendor material.
- Calibration is treated as the central problem rather than discrimination, which is the right emphasis for a model that will move between institutions.
- The model class is named and the certification carries an adjunctive constraint, so intended use is written down rather than implied.
- Its founding argument is that prediction was never the constraint, and it builds around intervention, bundle completion and workflow instead.
- The commercial disclosure is the best in this category and it publishes a genuine implementation ladder with timelines attached.
- The mechanism is described plainly enough that you can tell exactly what the product does, which is rare in a lane full of proprietary scores.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Healthplus.ai and Luminare are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Healthplus.ai | Luminare |
|---|---|---|
| Primary category | Inpatient Deterioration & Risk Monitoring | Inpatient Deterioration & Risk Monitoring |
| Founded | Not recorded | 2014 |
| Headquarters | Netherlands | Houston, Texas |
| Website | healthplus.ai | luminare.io |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Healthplus.ai its top capability grade on AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Set against Luminare, Healthplus.ai grades higher on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for Luminare on any axis it scores. Set against Healthplus.ai, Luminare grades higher on Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Healthplus.ai or Luminare?
On the axes where the AI Health Index separates them, Healthplus.ai grades higher on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence, and Luminare grades higher on Commercial Transparency. Healthplus.ai leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Healthplus.ai and Luminare differ most?
The widest separation the AI Health Index records between Healthplus.ai and Luminare is on AI Centrality, where Healthplus.ai grades A and Luminare grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Healthplus.ai and Luminare grade the same?
The AI Health Index grades Healthplus.ai and Luminare the same on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Inpatient Deterioration & Risk Monitoring page.
The regulatory positions differ and are not equivalent: one is certified in Europe as software as a medical device with an adjunctive constraint, the other is not cleared and states it operates without clearance on the basis of the claims it makes, and it is not currently available for clinical use in the United States in the first case, so check status before evaluating.
Luminare's central argument rests on a review article its own chief executive co authored, which is a stated position rather than independent evidence. Neither publishes an alert burden per patient day.